Wholesale Distributor
Thank you for contacting us; we’ll be in touch shortly.
DSCSA 2023 Preparation Continues to Accelerate with VRS R1.3 Network Ecosystem Upgrade
TraceLink collaborates with the industry to roll out important enhancements to the verification router service (VRS) network ecosystem to help pharma…
Is Your DSCSA VRS Vendor Exiting the Market? TraceLink’s Network-Based Product Verification and Master Data Sharing Solution is the Proven, Risk-Free Path to Rapid Compliance!
A shift in one VRS vendor’s market strategy may jeopardize many pharma companies’ ability to meet DSCSA 2023 requirements. Watch this webinar to see…
Proven Mobility Solution Delivers a Faster, Better Way to Manage Serialized Warehouse Operations
Learn how Smart Inventory Tracker from TraceLink delivers a faster, better way to manage serialized warehouse operations and ensure compliance with…
A Wholesale Distributor's Point of View: What is Required from Manufacturers for DSCSA 2023?
Ashley DeFlice, Regulatory Affairs Specialist at wholesale distributor Henry Schein, explains why pharmaceutical manufacturers must act with urgency…
From Surviving to Thriving: How Supply Chain Leaders Drive Revenue Growth by Digitalizing the Supply Chain
Global challenges are forcing leaders to rethink how they manage supply chains—and specifically how they work with partners.
What Do Wholesalers & Retail Pharmacies Expect from Manufacturers for DSCSA 2023?
As a pharmaceutical manufacturer, you know that complying with DSCSA 2023 is important for your own operations
Drug Shortages: Digital Supply Chains Offer New Hope in Effort to Ensure Patient Access to Medicine
Learn why digital supply networks and collective intelligence have emerged as the newest weapons in the battle against drug shortages.
DSCSA 2023 Webinar Series: How to Ensure Supply and Create Business Value with DSCSA Compliance for Drug Manufacturers and Wholesale Distributors
How to Ensure Drug Supply and Create Business Value with DSCSA Compliance for Manufacturers & Wholesale Distributors
DSCSA 2023: What is the Process for Handling an Illegitimate Product?
Learn what dispensers need to do to ensure a safe drug supply when a potentially illegitimate product is identified.
DSCSA 2023: How Does the FDA Define “Suspect Product”?
Learn how recent FDA guidance provides more detailed definitions to help dispensers identify a suspect product.
Pharmacies and Recalls: Understanding the Impact—and Changes to Come
Read about how drug-related recalls affect pharmacies' operational efficiency, how to be proactive on recalls, and how serialization can help.
McKesson Q&A: The Challenge of Saleable Returns Verification
Read how McKesson is getting ready for the DSCSA saleable returns verification requirement, and how to handle DSCSA compliance in the face of it.